Found: 10
Select item for more details and to access through your institution.
The comparison of plasma arsenic concentration and urinary arsenic excretion during treatment with Realgar-Indigo naturalis formula and arsenic trioxide in children with acute promyelocytic leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 45, doi. 10.1007/s00280-022-04449-9
- By:
- Publication type:
- Article
Evaluation of drug–drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 19, doi. 10.1007/s00280-022-04448-w
- By:
- Publication type:
- Article
Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 29, doi. 10.1007/s00280-022-04446-y
- By:
- Publication type:
- Article
Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acknowledgement of reviewers 2021.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 105, doi. 10.1007/s00280-022-04420-8
- Publication type:
- Article
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Exposure-response analyses for the MET inhibitor tepotinib including patients in the pivotal VISION trial: support for dosage recommendations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 1, doi. 10.1007/s00280-022-04439-x
- By:
- Publication type:
- Article
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 97, doi. 10.1007/s00280-022-04437-z
- By:
- Publication type:
- Article
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 1, p. 7, doi. 10.1007/s00280-022-04443-1
- By:
- Publication type:
- Article